| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000027129 |
| Receipt No. | R000031088 |
| Official scientific title of the study | Effect of docetaxel, estramustine and carboplatin chemotherapy on castration-resistant prostate cancer |
| Date of disclosure of the study information | 2017/05/01 |
| Last modified on | 2017/04/25 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Effect of docetaxel, estramustine and carboplatin chemotherapy on
castration-resistant prostate cancer |
|
| Title of the study (Brief title) | DEC | |
| Region |
|
|
| Condition | ||
| Condition | CRPC | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To exam the efficacy of DEC on CRPC |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | survival, QOL |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Chemotherapy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1 Male
2 Older tha 18 3 Patients agree with this study |
|||
| Key exclusion criteria | 1 Patients who can not visit our hospitall
2 History of allergy on DEC agents 3 Patiens whom the doctor don't think appropriate |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiro Sumura |
| Organization | Shimane University |
| Division name | Urology |
| Address | Enya 89-1, Izumo, Shimane |
| TEL | 0853202256 |
| sumura@med.shimane-u.ac.jp | |
| Public contact | |
| Name of contact person | Masahiro Sumura |
| Organization | Shimane University |
| Division name | Urology |
| Address | Enya 89-1, Izumo, Shimane |
| TEL | 0853202256 |
| Homepage URL | |
| sumura@med.shimane-u.ac.jp | |
| Sponsor | |
| Institute | Shimane University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shimane University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031088 |